Skip to main content
. 2020 Oct 13;115(4):720–775. [Article in Portuguese] doi: 10.36660/abc.20201047

Table 58. Step 5: Type of severe multivalvular disease intervention163165.

Type Considerations
Percutaneous balloon mitral valvuloplasty
  • Cases of severe MS with favorable anatomy and moderate aortic valvular heart disease

Surgical treatment (commissurotomy or valve replacement)
  • Conservative mitral valve surgery when stenosis is predominant

  • Avoid aortic valve repair – frequent recurrence of valvular heart disease and symptoms, even with good immediate results

  • Treatment of anatomically moderate valvular heart disease concomitant to intervention for severe valvular disease

Transcatheter treatment – valve-in-valve
  • Mitral and aortic bioprosthesis dysfunction, in symptomatic patients who have high surgical risk or are inoperable (following evaluation by the Heart Team)

Transcatheter treatment – TAVI and percutaneous mitral repair
  • Severe AS and severe primary MR, in patients with symptoms and/or prognostic factors, when there is a high surgical risk or contraindication to surgery (following evaluation by the Heart Team)

MR: mitral regurgitation; MS: mitral stenosis; TAVI: transcatheter aortic valve implantation.